vRad announces new patent for escalating radiology procedures through AI

vRad, a MEDNAX company, announced this week that it has secured a patent for using artificial intelligence (AI) to escalate high-priority radiology procedures.

The patent, officially titled “Medical Evaluation Machine Learning Workflows and Processes,” is vRad’s 18th overall.

Shannon Werb, the company’s president and chief operating officer, said in a prepared statement that the patent will help vRad, and MEDNAX, provide patients with high-quality care.

“This latest patent highlights the value MEDNAX radiology, powered by the vRad platform, creates by providing better overall patient care,” Werb said. “We are focusing our artificial intelligence strategy on helping doctors do a better job by removing obstacles and elevating their reading experience where their technical efficiency and interpretive accuracy are maximized. Our goal is to improve overall interpretation accuracy, speed, and quality so that our network of radiologists can focus on what they do best—taking great care of patients.”

Michael Walter
Michael Walter, Managing Editor

Michael has more than 19 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

The new F-18 flurpiridaz radiotracer is expected to help drive cardiac PET growth, but it requires waiting between rest and stress scans. Software from MultiFunctional Imaging can help care teams combat that problem.

News of an incident is a stark reminder that healthcare workers and patients aren’t the only ones who need to be aware around MRI suites.

The ACR hopes these changes, including the addition of diagnostic performance feedback, will help reduce the number of patients with incidental nodules lost to follow-up each year.